Bone morphogenetic protein 2 therapy for craniofacial surgery

Journal of Craniofacial Surgery

Volumn 19, Issue 5, 2008, Pages 1244-1259

  Smith, Darren M ^a   Cooper, Gregory M ^a   Mooney, Mark P ^a   Marra, Kacey G ^a   Losee, Joseph E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

BMP 2; Craniofacial surgery; Cranioplasty; Pediatric; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; SMAD PROTEIN; BONE MORPHOGENETIC PROTEIN; INHIBITORY SMAD PROTEIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE REMODELING; CARCINOGENESIS; CRANIOFACIAL SURGERY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HETEROTOPIC OSSIFICATION; HUMAN; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; MORBIDITY; NEUROTOXICITY; NONHUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; ANIMAL; BONE REGENERATION; CRANIOFACIAL MALFORMATION; CRANIOTOMY; OSTEOBLAST; PHYSIOLOGY; REVIEW; SKULL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIOFACIAL ABNORMALITIES; CRANIOTOMY; HUMANS; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SKULL; SMAD PROTEINS, INHIBITORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 58249092177     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181843312     Document Type: Article

References (136)

1. Cowan CM, Aalami OO, Shi YY, et al. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 2005; 11:645Y658
2. Wan DC, Aalami OO, Wang Z, et al. Differential gene expression between juvenile and adult dura mater: a window into what genes play a role in the regeneration of membranous bone. Plast Reconstr Surg2006;118:851Y861
3. David L, Argenta L, Fisher D. Hydroxyapatite cement in pediatric craniofacial reconstruction. J Craniofac Surg2005;16: 129Y133
4. Cho YR, Gosain AK. Biomaterials in craniofacial reconstruction. Clin Plast Surg 2004;31:377Y385
5. McCarthy JG, Stelnicki EJ, Mehrara BJ, et al. Distraction osteogenesis of the craniofacial skeleton. Plast Reconstr Surg2001;107:1812Y1827
6. Baskin DS, Ryan P, Sonntag V, et al. A prospective, randomized, controlled cervical fusion study using recombi-nant human bone morphogenetic protein-2 with the COR-NERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine2003;28:1219Y1225
7. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg2005;63:1693Y1707
8. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17:11Y25
9. Boyne PJ, Nakamura A, Shabahang S. Evaluation of the long-term effect of function on rhBMP-2 regenerated hemiman-dibulectomy defects. Br J Oral Maxillofac Surg1999;37: 344Y352
10. Carstens MH, Chin M, Ng T, et al. Reconstruction of L7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg2005;16: 1023Y1032
11. Chin M, Carstens MH. Distraction osteogenesis with bone morphogenetic protein enhancement: facial cleft repair in humans. In: Proceedings of the 4th International Congress on Cranial and Facial Distraction Processes. Bologna, Italy: Monduzzi Publishing, July 3-6, 2003
12. Chin M, Ng T, Tom WK, et al. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg2005;16:778Y789
13. Cochran DL, Jones AA, Lilly LC, et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol2000;71: 1241Y1257
14. White KK, Bawa M, Ahn JS, et al. Strut allograft union and remodeling using rhBMP-2 in a spinal corpectomy model. Spine2005;30:1386Y1395
15. Minamide A, Tamaki T, Kawakami M, et al. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Spine 1999;24:1863Y1870
16. Urist MR. Bone: formation by autoinduction. Science1965;150: 893Y899
17. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res1998;26Y37
18. De Biase P, Capanna R. Clinical applications of BMPs. Injury2005;36:S43YS46
19. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004;11:1312Y1320
20. Sarras MP Jr. BMP-1 and the astacin family of metallopro-teinases: a potential link between the extracellular matrix, growth factors and pattern formation. Bioessays1996;18: 439Y442
21. Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci2006;1068:19Y25
22. Wutzl A, Brozek W, Lernbass I, et al. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A2006;77:75Y83
23. Chung UI, Kawaguchi H, Takato T, et al. Distinct osteogenic mechanisms of bones of distinct origins. J Orthop Sci2004;9: 410Y414
24. Simic P, Vukicevic S. Bone morphogenetic proteins in development. In: Vukicevic S, Sampath KT, eds. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond.Basel, Switzerland: Birkhauser Verlag, 2004:73Y108
25. Sampath KT. Bone morphogenetic proteins and their role in regenerative medicine. In: Vukicevic S, Sampath KT, eds. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Basel, Switzerland: Birkhauser Verlag, 2004:1Y8
26. Ripamonti U. The generation of bone in primates by bone morphogenetic proteins. In: Lindholm TS, ed. Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery.RG Landes Company, 1996
27. Itoh K, Udagawa N, Katagiri T, et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology2001;142: 3656Y3662
28. Kim YJ, Lee MH, Wozney JM, et al. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem2004;279: 50773Y50780
29. Spinella-Jaegle S, Roman-Roman S, Faucheu C, et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone2001; 29:323Y330
30. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFbeta family members. J Orthop Sci2003;8:740Y748
31. Skillington J, Choy L, Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 2002;159:135Y146
32. Kochynskyi O, Bezooijen RLv, Lowik CWGM, et al. Bone morphogenetic protein receptors and their nuclear effectors in bone formation. In: Vukicevic S, Sampath KT, eds. Bone Morphogenetic Proteins: Regeneration of Bone and Beyond.Basel, Switzerland: Birkhauser Verlag, 2004:9Y44
33. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol2000; 20:8783Y8792
34. Lee KS, Hong SH, Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene2002;21:7156Y7163
35. Zaidi SK, Sullivan AJ, van Wijnen AJ, et al. Integration of Runx and Smad regulatory signals at transcriptionally active sub-nuclear sites. Proc Natl Acad Sci USA 2002;99:8048Y8053
36. Ryoo HM, Lee MH, Kim YJ. Critical molecular switches involved in BMP-2Yinduced osteogenic differentiation of mesenchymal cells. Gene2005
37. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem2006;99:1233Y1239
38. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108:17Y29
39. Morinobu M, Nakamoto T, Hino K, et al. The nucleocytoplas-mic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med2005;201:961Y9700.
40. Shen ZJ, Nakamoto T, Tsuji K, et al. Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. J Biol Chem 2002;277:29840Y29846
41. Sapkota G, Alarcon C, Spagnoli FM, et al. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell2007;25:441Y454
42. Lee MH, Kim YJ, Kim HJ, et al. BMP-2Yinduced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2Yinduced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem2003;278:34387Y34394
43. Roth DA, Longaker MT, McCarthy JG, et al. Studies in cranial suture biology, part I: increased immunoreactivity for TGFbeta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J Bone Miner Res1997;12:311Y321
44. Poisson E, Sciote JJ, Koepsel R, et al. Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J2004;41: 392Y402
45. Hong JH, Hwang ES, McManus MT, et al. TAZ, a transcrip-tional modulator of mesenchymal stem cell differentiation. Science2005;309:1074Y107846.
46. Hong JH, Yaffe MB. TAZ: a beta-cateninYlike molecule that regulates mesenchymal stem cell differentiation. Cell Cycle2006;5:176Y179
47. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233Y241
48. Goldstein AM, Brewer KC, Doyle AM, et al. BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system. Mech Dev2005;122: 821Y833
49. Knosp WM, Scott V, Bachinger HP, et al. HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis. Development2004;131: 4581Y4592
50. Lincoln J, Alfieri CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol2006;292:292Y302
51. Machingo QJ, Fritz A, Shur BD. A beta1,4-galactosyltransfer-ase is required for BMP2-dependent patterning of the dorsoventral axis during zebrafish embryogenesis. Development2006;133:2233Y2241
52. Nilsson OS, Urist MR. Immune inhibition of repair of canine skull trephine defects implanted with partially purified bovine morphogenetic protein. Int Orthop1991; 15:257Y263
53. Urist MR, Hudak RT, Huo YK, et al. Osteoporosis: a bone morphogenetic protein auto-immune disorder. Prog Clin Biol Res1985;187:77Y9654.
54. Ma55bie PC, Mehler MF, Kessler JA. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci1999;19: 7077Y7088
55. Ebendal T, Bengtsson H, Soderstrom S. Bone morphogenetic proteins and their receptors: potential functions in the brain. J Neurosci Res1998;51:139Y146
56. Fukuda S, Taga T. Cell fate determination regulated by a transcriptional signal network in the developing mouse brain. Anat Sci Int2005;80:12Y18
57. Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development1997;124:2203Y2212
58. Zhang D, Mehler MF, Song Q, et al. Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J Neurosci 1998;18:3314Y3326
59. Sheehan JP, Sheehan JM, Seeherman H, et al. The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. J Neurosurg 2003;98:125Y130
60. obb WA, Guiloff RJ, Cast J. Breach rhythm: the EEG related to skull defects. Electroencephalogr Clin Neurophysiol1979;47: 251Y271
61. Meyer RA Jr, Gruber HE, Howard BA, et al. Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine1999;24:747Y754
62. Martin GJ Jr, Boden SD, Marone MA, et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord1999;12: 179Y186
63. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone2005;36:745Y757
64. Arnander C, Westermark A, Veltheim R, et al. Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J Craniofac Surg2006;17: 275Y279
65. Chao M, Donovan T, Sotelo C, et al. In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduc-tion via stem cell concentration. J Craniofac Surg2006;17: 405Y412
66. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev2003;55: 1613Y1629
67. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent1997;17:124Y139
68. Sailer HF, Kolb E. Application of purified bone morphogenetic protein (BMP) preparations in cranio-maxillo-facial surgery. Reconstruction in craniofacial malformations and post-traumatic or operative defects of the skull with lyophilized cartilage and BMP. J Craniomaxillofac Surg 1994;22:191Y199
69. Hsu MY, Rovinsky S, Penmatcha S, et al. Bone morphogenetic proteins in melanoma: angel or devil? Cancer Metastasis Rev2005;24:251Y263
70. Jin Y, Tipoe GL, Liong EC, et al. Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium. Oral Oncol2001;37:225Y233
71. Bradley J. Panel 2: bone morphogenetic proteins. In: International Society of Craniofacial Surgery: Biennial International Conference.Bahia, Brazil, 2007
72. Carstens M. Clinical applications of recombinant human bone morphogenetic protein in craniofacial surgery. In: International Society of Craniofacial Surgery: Biennial International Conference.Bahia, Brazil, 2007
73. Podda S, Wolfe SA. Switch cranioplasty and BMP-2 in a hemicranial reconstruction in an infant. In: International Society of Craniofacial Surgery: Biennial International Conference. Bahia, Brazil, 2007
74. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542Y547
75. McKay WF, Peckham SM, Marotta JS. The Science of rhBMP-2.St Louis, MA: Quality Medical Publishing Inc, 2006
76. Chang CF, Lin SZ, Chiang YH, et al. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke2003;34:558Y564
77. Lindholm TC, Lindholm TS, Marttinen A, et al. Bovine bone morphogenetic protein (bBMP/NCP)-induced repair of skull trephine defects in pigs. Clin Orthop Relat Res 1994:263Y270
78. Kanzler B, Foreman RK, Labosky PA, et al. BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development2000;127:1095Y1104
79. Piscione TD, Yager TD, Gupta IR, et al. BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. Am J Physiol1997;273: F961YF975
80. Marden LJ, Hollinger JO, Chaudhari A, et al. Recombinant human bone morphogenetic protein-2 is superior to deminer-alized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res1994;28:1127Y1138
81. Ripamonti U, Magan A, Ma S, et al. Xenogeneic osteogenin, a bone morphogenetic protein, and demineralized bone matrices, including human, induce bone differentiation in athymic rats and baboons. Matrix1991;11:404Y411
82. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg1982;196:100Y109
83. Arnaud E, De Pollak C, Meunier A, et al. Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty. Biomaterials1999;20: 1909Y1918
84. Murata M, Maki F, Sato D, et al. Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum. Clin Oral Implants Res 2000;11:289Y295
85. Murata M, Huang BZ, Shibata T, et al. Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int J Oral Maxillofac Surg1999;28:232Y237
86. Haddad AJ, Peel SA, Clokie CM, et al. Closure of rabbit calvarial critical-sized defects using protective composite allogeneic and alloplastic bone substitutes. J Craniofac Surg 2006;17:926Y934
87. Hollinger JO, Schmitt JM, Buck DC, et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res1998;43:356Y364
88. Lindholm TC, Lindholm TS, Alitalo I, et al. Bovine bone morphogenetic protein (bBMP) induced repair of skull trephine defects in sheep. Clin Orthop Relat Res1988;227: 265Y268
89. Sato K, Urist MR. Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop Relat Res1985:301Y311
90. Ferguson D, Davis WL, Urist MR, et al. Bovine bone morphogenetic protein (bBMP) fraction-induced repair of craniotomy defects in the rhesus monkey (Macaca speciosa). Clin Orthop Relat Res1987;251Y258
91. Hollinger J, Mark DE, Bach DE, et al. Calvarial bone regeneration using osteogenin. J Oral Maxillofac Surg1989;47: 1182Y1186
92. Hollinger JO, Schmitz JP, Mark DE, et al. Osseous wound healing with xenogeneic bone implants with a biodegradable carrier. Surgery1990;107: 50Y54
93. Ripamonti U. Bone induction in nonhuman primates. An experimental study on the baboon. Clin Orthop Relat Res1991;284Y294
94. Ripamonti U, Ma S, Cunningham NS, et al. Initiation of bone regeneration in adult baboons by osteogenin, a bone morpho-genetic protein. Matrix1992;12:369Y380
95. Ripamonti U, Ma SS, Cunningham NS, et al. Reconstruction of the boneVbone marrow organ by osteogenin, a bone morphogenetic protein, and demineralized bone matrix in calvarial defects of adult primates. Plast Reconstr Surg1993;91:27Y36
96. Ripamonti U, Ma SS, Reddi AH. Induction of bone in composites of osteogenin and porous hydroxyapatite in baboons. Plast Reconstr Surg1992;89:731Y739
97. Ripamonti U, Ma SS, van den Heever B, et al. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg1992; 90:382Y393
98. Takahashi Y, Yamamoto M, Yamada K, et al. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007;13:293Y300
99. Kaneko H, Arakawa T, Mano H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteo-clasts. Bone2000;27:479Y486
100. Koide M, Murase Y, Yamato K, et al. Bone morphogenetic protein-2 enhances osteoclast formation mediated by inter-leukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun1999;259:97Y102
101. Kanatani M, Sugimoto T, Kaji H, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res1995;10: 1681Y1690
102. Saneshige S, Mano H, Tezuka K, et al. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem J1995;309:721Y724
103. Scheven BA, Hamilton NJ. Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms. Bone1990;11:53Y59
104. Springer IN, Acil Y, Kuchenbecker S, et al. Bone graft versus BMP-7 in a critical size defectVcranioplasty in a growing infant model. Bone2005;37:563Y569
105. Mooney MP, Siegel MI. Animal models for bone tissue engineering of critical-sized defects (CSDs), bone pathologies, and orthopedic disease states. In: Hollinger JO, Einhorn TA, Doll BA, et al, eds. Fundamentals of Bone Tissue Engineering.Boca Raton, FL: CRC Press, 2005:217Y244
106. Medtronic. Available at: http://wwwp.medtronic.com/ Newsroom/ NewsReleaseDetails.do?itemId=1096482027073& lang=en-US
107. Toriumi DM, Kotler HS, Luxenberg DP, et al. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg1991;117: 1101Y1112
108. Toriumi DM, O'Grady K, Horlbeck DM, et al. Mandibular reconstruction using bone morphogenetic protein 2: long-term follow-up in a canine model. Laryngoscope1999;109: 1481Y1489
109. Uludag H, Gao T, Porter TJ, et al. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am2001;83-A:S128YS135
110. Li RH, Wozney JM. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol2001;19:255Y265
111. Ripamonti U, Ramoshebi LN, Matsaba T, et al. Bone induction by BMPs/OPs and related family members in primates. J Bone Joint Surg Am2001;83-A:S116YS127
112. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine2003;28:429Y434
113. Suh DY, Boden SD, Louis-Ugbo J, et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine2002;27: 353Y360
114. Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine2001;26:933Y939
115. Minamide A, Kawakami M, Hashizume H, et al. Experimental study of carriers of bone morphogenetic protein used for spinal fusion. J Orthop Sci2004;9:142Y151
116. Hori Y, Nakamura T, Kimura D, et al. Effect of basic fibroblast growth factor on vascularization in esophagus tissue engineering. Int J Artif Organs2003;26:241Y244
117. Hori Y, Nakamura T, Matsumoto K, et al. Experimental study on in situ tissue engineering of the stomach by an acellular collagen sponge scaffold graft. ASAIO J2001;47:206Y210
118. Hori Y, Nakamura T, Matsumoto K, et al. Tissue engineering of the small intestine by acellular collagen sponge scaffold grafting. Int J Artif Organs2001;24:50Y54
119. Leipziger LS, Glushko V, DiBernardo B, et al. Dermal wound repair: role of collagen matrix implants and synthetic polymer dressings. J Am Acad Dermatol1985;12:409Y419
120. Morimoto N, Saso Y, Tomihata K, et al. Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation. J Surg Res2005;125:56Y67
121. Barnes B, Boden SD, Louis-Ugbo J, et al. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconduc-tive bulking agent in non-human primates. Spine2005;30: 1127Y1133
122. Rickard DJ, Sullivan TA, Shenker BJ, et al. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol1994;161: 218Y228
123. Kataoka H, Urist MR. Transplant of bone marrow and muscle-derived connective tissue cultures in diffusion chambers for bioassay of bone morphogenetic protein. Clin Orthop Relat Res1993;262Y270
124. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell2002;13: 4279Y4295
125. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng2001;7:211Y228
126. Halvorsen YD, Franklin D, Bond AL, et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 2001;7: 729Y741
127. Dragoo JL, Choi JY, Lieberman JR, et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res2003;21:622Y629
128. Wickham MQ, Erickson GR, Gimble JM, et al. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop2003;196Y212
129. Gronthos S, Franklin DM, Leddy HA, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol2001;189:54Y63
130. Toyoda H, Terai H, Sasaoka R, et al. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone2005;37: 555Y562
131. Chikazu D, Li X, Kawaguchi H, et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002. J Bone Miner Res2005; 20:1888Y1898
132. Weinreb M, Grosskopf A, Shir N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol1999;276:E376YE383
133. Weinreb M, Shamir D, Machwate M, et al. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Prosta-glandins Leukot Essent Fatty Acids 2006;75:81Y90
134. Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest2002;109:1405Y1415
135. Warren SM, Brunet LJ, Harland RM, et al. The BMP antagonist Noggin regulates cranial suture fusion. Nature2003;422:625Y629
136. Wan D, Pomerantz JH, Nacamuli RP, et al. siRNA mediated Noggin suppression enhances osteoblast differentiation and mineral deposition. Plast Reconstr Surg2005;116:55